Showing results (1791-1800 of 3,529) with videos related to
Sort By:
Pageof 353
Thoracic Cancer|October 17, 2018
Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancerPuyuan Xing, Yuxin Mu, Yan Wang, et al.Thoracic Cancer|September 21, 2021
Immune checkpoint inhibitors for first-line treatment of advanced non-small-cell lung cancer: A systematic review and network meta-analysisTzu-Rong Peng, Hung-Hong Lin, Fang-Pei Tsai, et al.Thoracic Cancer|April 5, 2021
Combination of nitrous oxide and the modified inflation-deflation method for identifying the intersegmental plane in segmentectomy: A randomized controlled trialWenjing Yang, Zicheng Liu, Chun Yang, et al.Thoracic Cancer|July 18, 2020
CDK4/6 inhibitor palbociclib overcomes acquired resistance to third-generation EGFR inhibitor osimertinib in non-small cell lung cancer (NSCLC)Qiong Qin, Xiaoqing Li, Xingmei Liang, et al.Thoracic Cancer|July 18, 2020
Clinical characteristics and management of primary mediastinal cysts: A single-center experienceXun Wang, Yun Li, Kezhong Chen, et al.Thoracic Cancer|July 18, 2020
Three-dimensional printed polyether-ether-ketone implant for extensive chest wall reconstruction: A case reportLei Wang, Xi Liu, Tao Jiang, et al.Thoracic Cancer|May 9, 2023
Mutations and expressions of breast cancer 1/2 in lung cancerBokang Yan, Bin Xie, Meiyuan Huang, et al.Thoracic Cancer|May 20, 2023
Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinomaNaoki Yanagawa, Shunsuke Shikanai, Mayu Sugai, et al.Thoracic Cancer|January 18, 2018
Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, ChinaYangBo Hu, Huan Hu, LiYun Miao, et al.Thoracic Cancer|January 18, 2018
Left sleeve lobectomy versus left pneumonectomy for the management of patients with non-small cell lung cancerLiang Wang, YuQuan Pei, ShaoLei Li, et al.Pageof 353